Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,964 public trials 1,826 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)

NCT05579132

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • The Second Affiliated Hospital of Third Military Medical University ( Site 0008) Chongqing, Chongqing Municipality, China
  • Southern Medical University Nanfang Hospital ( Site 0004) Guangzhou, Guangdong, China
  • The Second Hospital of Hebei Medical University ( Site 0003) Shijiazhuang, Hebei, China
  • The First Hospital of Harbin ( Site 0005) Harbin, Heilongjiang, China
View Trial Details
Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

NCT07109219

Conditions
B-cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Iowa City, Iowa, United States
View all 26 locations
View Trial Details
Recruiting

A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

NCT06725030

Conditions
Anastomosis, Surgical, Free Tissue Transfer, Hemic and Lymphatic Diseases, +4 more
Locations
  • Cedars Sinai Medical Center Beverly Hills, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Tampa General Hospital Tampa, Florida, United States
  • Erie County Medical Center Buffalo, New York, United States
View Trial Details
Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

NCT05852717

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Center (Wayne State University) Detroit, Michigan, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • University of Virginia Health System Charlottesville, Virginia, United States
View Trial Details
Recruiting

Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma

NCT06558604

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Az Sint-Jan Brugge - Oostende Av Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Chu de Liege Liège, Belgium
  • Chu Ucl Namur - Site Godinne Yvoir, Belgium
View all 16 locations
View Trial Details
Recruiting

A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies

NCT07308132

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Monash Medical Centre Clayton, Australia
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • Macquarie University Hospital North Ryde, Australia
  • Scientia Clinical Research Randwick, Australia
View all 19 locations
View Trial Details

Related conditions